Albuminuria in chronic heart failure: prevalence and prognostic importance (Q43291306)

18 November 2017

Albuminuria in chronic heart failure: prevalence and prognostic importance (English)

1 reference

18 November 2017

0 references

chronic heart failure

1 reference

3

1 reference

18 November 2017

Christopher B. Granger

7

object named as

Christopher B Granger

1 reference

18 November 2017

8

Karl Swedberg

1 reference

18 November 2017

10

Salim Yusuf

1 reference

18 November 2017

11

John J V McMurray

1 reference

18 November 2017

9

Marc A Pfeffer

1 reference

CHARM Investigators and Committees

18 November 2017

12

object named as

CHARM Investigators and Committees

1 reference

18 November 2017

6

Eric L Michelson

1 reference

18 November 2017

4

Sofia Zetterstrand

1 reference

18 November 2017

Colette E Jackson

1

1 reference

18 November 2017

Scott D Solomon

2

1 reference

18 November 2017

Bertil Olofsson

5

1 reference

18 November 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

18 November 2017

1 reference

18 November 2017

374

1 reference

18 November 2017

9689

1 reference

18 November 2017

543-550

1 reference

Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study

18 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

2007 Guidelines for the Management of Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Albuminuria reflects widespread vascular damage. The Steno hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Microalbuminuria: what is it? Why is it important? What should be done about it? An update

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Microalbuminuria and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

High prevalence of microalbuminuria in chronic heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

The association between congestive heart failure and chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Predictors of mortality and morbidity in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Enalapril prevents clinical proteinuria in diabetic patients with low ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Influence of proteinuria on cardiovascular risk and response to angiotensin-converting enzyme inhibition after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

The pathogenesis of proteinuria in the acutely congested kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961378-7

7 January 2021

10.1016/S0140-6736(09)61378-7

Identifiers

DOI

1 reference

18 November 2017

1 reference